Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sana Biotechnology, Inc. | 80,000 | reported | 05 Jun 2025 | tx 8+368,073 |
| Gossamer Bio, Inc. | 30,000 | reported | 09 Jun 2022 | tx 4+100,500 |
| ViewRay, Inc. | 18,964 | reported | 13 Sept 2016 | tx 1+18,964 |
| T2 Biosystems, Inc. | 17,647 | reported | 17 Jun 2016 | tx 2+35,294 |
| Loxo Oncology, Inc. | 0 | reported | 15 Feb 2019 | tx 265+1,573,500−2,152,151 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2025 | GRANT_AWARD | Sana Biotechnology, Inc. | 80,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Sana Biotechnology, Inc. | 54,278 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Sana Biotechnology, Inc. | 65,000 | 0.00 USD | deriv |
| 03 Feb 2021 | PURCHASE | Sana Biotechnology, Inc. | 20,000 | 25.00 USD | |
| 09 Jun 2022 | GRANT_AWARD | Gossamer Bio, Inc. | 30,000 | 0.00 USD | deriv |
| 06 Jun 2022 | GRANT_AWARD | Sana Biotechnology, Inc. | 65,000 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Gossamer Bio, Inc. | 23,500 | 0.00 USD | deriv |
| 03 Feb 2021 | GRANT_AWARD | Sana Biotechnology, Inc. | 7,000 | 0.00 USD | deriv |
| 17 Jun 2020 | GRANT_AWARD | Gossamer Bio, Inc. | 23,500 | 0.00 USD | deriv |
| 10 Jun 2019 | GRANT_AWARD | Gossamer Bio, Inc. | 23,500 | 0.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 162,707 | 235.00 USD | |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 30,000 | 235.00 USD | |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 209,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 128,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 100,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 27,459 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 64,471 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 318,514 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 142,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 300,000 | 235.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Loxo Oncology, Inc. | 128,000 | 0.00 USD | deriv |
| 11 Dec 2018 | SALE | Loxo Oncology, Inc. | 647 | 134.63 USD | |
| 11 Dec 2018 | EXERCISE | Loxo Oncology, Inc. | 10,000 | 13.67 USD | |
| 10 Dec 2018 | EXERCISE | Loxo Oncology, Inc. | 10,000 | 13.67 USD | |
| 10 Dec 2018 | SALE | Loxo Oncology, Inc. | 969 | 130.58 USD |